University of Southampton
Multi-omics analysis of a Zika virus-based oncolytic virotherapy
Abstract
dc:description.abstractZika virus (ZIKV) is a mosquito-borne virus belonging to the Flaviviridae family. Recent studies have indicated that ZIKV has potential as a novel candidate for oncolytic virotherapy in central nervous system (CNS) tumours, including paediatric brain tumours, owning to its neurotropism and ability to kill tumour cells in vitro, as well as reducing tumour growth and extending survival in vivo. Neuroblastoma, the most common tumour in children under five years old, is a malignancy of the sympathetic nervous system. ZIKV’s neurotropism makes it an attractive candidate for investigation as a treatment for neuroblastoma. However, although previous studies have demonstrated ZIKV’s potential as an oncolytic therapy, the underlying mechanisms remains poorly understood, and the roles of ZIKV proteins in tumours have rarely been explored. Therefore, the aim of this study is to investigate the oncolytic effect of ZIKV on neuroblastoma and the functions of its non-structural proteins in paediatric tumours using both neuroblastoma and paediatric brain tumour models. Results showed that ZIKV exerted a potent oncolytic effect in both 2D and 3D neuroblastoma models, with higher multiplicity of infection (MOI) producing a stronger reduction in tumoursphere size and 3D viability compared with lower MOI. Transcriptomic analysis of ZIKV-infected neuroblastoma tumourspheres revealed significant downregulation of biological processes related to cell adhesion and extracellular matrix organisation, findings that were consistent with RNA-Seq data from ZIKV-infected paediatric brain tumour cells, where pathways including cell-matrix adhesion and integrin-mediated signalling were similarly suppressed. To explore the role of ZIKV non-structural proteins in mediating the effects of ZIKV on tumours, affinity proteomics was performed, which identified integrin alpha-3 as a key interactor with NS2B and NS4A in both neuroblastoma and paediatric brain tumour. Functional assays demonstrated that integrin alpha-3 depletion partially rescued the reduction in tumoursphere size induced by ZIKV and NS4A in paediatric brain tumour cells, independent of changes in NS4A expression, ZIKV-induced cell viability, or viral titre. Furthermore, integrin alpha-3 and ZIKV additively suppressed 3D invasion, highlighting the therapeutic potential of combining ZIKV-based virotherapy with integrin-targeting strategies. Collectively, these findings provide mechanistic insights into ZIKV-mediated oncolysis and metastasis inhibition, offering promising avenues for novel treatments in paediatric tumours.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Sui, Yi
- Advisors dc:contributor.advisor
-
- Ewing, Rob
- Wang, Yihua
- Maringer, Kevin
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng
Identifiers
dc:identifier.*- DOI dc:identifier.doi
- https://doi.org/10.5258/SOTON/PG/T164